Login / Signup
Detecting pulmonary malignancy against benign nodules using noninvasive cell-free DNA fragmentomics assay.
S Xu
J Luo
W Tang
H Bao
J Wang
S Chang
Z Zou
X Fan
Y Liu
C Jiang
X Wu
Published in:
ESMO open (2024)
Our cfDNA fragmentomics assay can provide a noninvasive approach to distinguishing malignant nodules from radiographically suspicious but pathologically benign ones, amending LDCT false positives.
Keyphrases
</>
high throughput
pulmonary hypertension